Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Fuchs, Charles S, Dr Prof, Tomasek, Jiri, MD, Yong, Cho Jae, Prof, Dumitru, Filip, MD, Passalacqua, Rodolfo, MD, Goswami, Chanchal, Prof, Safran, Howard, Prof, dos Santos, Lucas Vieira, MD, Aprile, Giuseppe, MD, Ferry, David R, Prof, Melichar, Bohuslav, Prof, Tehfe, Mustapha, MD, Topuzov, Eldar, Prof, Zalcberg, John Raymond, Prof, Chau, Ian, MD, Campbell, William, Prof, Sivanandan, Choondal, MD, Pikiel, Joanna, MD, Koshiji, Minori, MD, Hsu, Yanzhi, PhD, Liepa, Astra M, PharmD, Gao, Ling, PhD, Schwartz, Jonathan D, MD, Tabernero, Josep, MD
Published in The Lancet (British edition) (04.01.2014)
Published in The Lancet (British edition) (04.01.2014)
Get full text
Journal Article
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Bang, Yung-Jue, Prof, Kim, Young-Woo, MD, Yang, Han-Kwang, Prof, Chung, Hyun Cheol, Prof, Park, Young-Kyu, Prof, Lee, Kyung Hee, Prof, Lee, Keun-Wook, Prof, Kim, Yong Ho, Prof, Noh, Sang-Ik, MD, Cho, Jae Yong, Prof, Mok, Young Jae, Prof, Kim, Yeul Hong, Prof, Ji, Jiafu, Prof, Yeh, Ta-Sen, Prof, Button, Peter, MSc, Sirzén, Florin, MD, Noh, Sung Hoon, Prof
Published in The Lancet (British edition) (28.01.2012)
Published in The Lancet (British edition) (28.01.2012)
Get full text
Journal Article